Doctor profile · Federal record
Dr. Michael Smith, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Internal Medicine Physician · Kansas City, MO
- NPI 1205871035
- Accepts Medicare
- MIPS 87.6 / 100 · 2023
- 21 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
4440 Broadway Blvd Ste 40
Kansas City, MO 641113315
(816) 531-0930
fax (816) 753-2671 - Additional location
-
4330 Wornall RD, Suite 40
Kansas City, MO 641113201
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- March 15, 2021
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (3)
- Missouri #2008017232 · New York #252911-1 · North Carolina #2010-00595
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1205871035. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
134,828
Distinct HCPCS
10
Medicare allowed
$2,474,130
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 49,200 | 12 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 29,240 | 15 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15,200 | 40 | $42 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 10,010 | 15 | $45 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 9,930 | 53 | $32 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 5,800 | 15 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 3,360 | 35 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 3,250 | 19 | $77 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,023 | 371 | $4 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 875 | 325 | $5 |
In context: peer comparison
Among 6 peers in Kansas City Rheumatology Physician, average services per provider: 3,614. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$750
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $750.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,982
Patients
808
Total drug cost
$362,275
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 890 | 242 | $76,537 |
| Methotrexate (Methotrexate Sodium) | Brand | 600 | 169 | $23,763 |
| Prednisone | Generic | 385 | 106 | $3,248 |
| Folic Acid | Generic | 199 | 60 | $958 |
| Meloxicam | Generic | 177 | 44 | $1,033 |
| Tramadol Hcl | Generic | 160 | 33 | $1,416 |
| Leflunomide | Generic | 156 | 40 | $9,299 |
| Sulfasalazine | Generic | 84 | 21 | $3,140 |
| Celecoxib | Generic | 70 | 21 | $1,730 |
| Allopurinol | Generic | 60 | 18 | $508 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Smith's medical specialty?
Dr. Michael Smith practices Rheumatology Physician in Kansas City, MO.
Where does Dr. Michael Smith practice?
Dr. Michael Smith practices at 4440 Broadway Blvd Ste 40, Kansas City, MO 641113315. Office phone: 8165310930.
What is Dr. Michael Smith's NPI?
Dr. Michael Smith's National Provider Identifier (NPI) is 1205871035, issued by NPPES.
Does Dr. Michael Smith accept Medicare assignment?
Yes. Dr. Michael Smith accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Smith commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.